This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Crane Holdings (CR) Business Unit Separation Set for April '23
by Zacks Equity Research
Crane Holdings (CR) expects the tax-free spin-off of its Payment and Merchandising Technologies business unit to be completed on Apr 3, 2023.
General Electric (GE) to Serve South Korean Offshore Wind Market
by Zacks Equity Research
General Electric (GE) unit, GE Renewable Energy's partnership with Hyundai Electric, advances South Korea's goal of adding 12GW of offshore wind by 2030.
Danaher (DHR) Up 14% in 6 Months: What's Driving the Stock?
by Zacks Equity Research
Danaher (DHR) gains from strength across its core Life Sciences segment, benefits from the DBS initiatives and acquired assets. The company's efforts to add shareholder value hold promise.
Honeywell (HON) Launches Program to Improve Building Health
by Zacks Equity Research
Honeywell's (HON) Healthy Building Services program is backed by assessments and certification systems from third-party organizations, allowing owners to improve overall building health.
Carlisle (CSL) Sets Goal to Achieve Net-Zero Emissions by 2050
by Zacks Equity Research
Carlisle (CSL) furthers its ESG journey by committing to achieve net-zero greenhouse gas emissions by 2050. The company aims to reduce emissions through the Science Based Targets Initiative.
Zebra Technologies (ZBRA) Picks New CEO as Gustafsson Steps Down
by Zacks Equity Research
Zebra Technologies (ZBRA) names Bill Burns as its next CEO, effective Mar 1, 2023, following the departure of long-serving CEO Anders Gustafsson.
General Electric (GE) HealthCare Arm Reveals Medium-Term Targets
by Zacks Equity Research
General Electric's (GE) HealthCare unit furnishes some of its medium-term targets at an investor day ahead of its planned spin-off into a separate public company on Jan 3, 2023.
Here's Why General Electric (GE) Shares are Down 10% YTD
by Zacks Equity Research
General Electric (GE) is plagued by persistent supply-chain disruptions, weakness in the Power and Renewable Energy segments and foreign currency headwinds.
4 Solid Stocks to Buy on Continued Rise in Factory Orders
by Ritujay Ghosh
Continued demand for durable goods is driving orders, which is helping stocks Hubbell Incorporated (HUBB), EnerSys (ENS), Applied Industrial Technologies, Inc. (AIT) and IDEX Corporation (IEX).
Here's Why Hold Strategy is Beneficial for Carlisle (CSL)
by Zacks Equity Research
Carlisle's (CSL) CCM segment stands to benefit from solid momentum in the U.S. reroofing end-market and new construction activity. Its efforts to reward shareholders with dividends augur well.
Tetra Tech (TTEK) Shares Up 11.3% in 6 Months: Here's Why
by Zacks Equity Research
Tetra Tech (TTEK) is benefiting from its focus on providing high-end consulting, design and engineering services, digital water transformation activities, acquired assets and shareholder-friendly measures.
Honeywell (HON), Nexceris Expand Partnership on EV Safety
by Zacks Equity Research
Amid growing demand for EVs, Honeywell (HON) and Nexceris team up to address safety concerns and develop sensor-based solutions to prevent thermal runaway in EV batteries.
Here's Why Investing in MRC Global (MRC) Makes Sense Now
by Zacks Equity Research
MRC Global (MRC) stands to benefit from strength in its gas utility sector owing to distribution integrity upgrade programs and new home. MRC's measures to reward its shareholders are encouraging.
Emerson (EMR) Selected as Automation Partner by KOHYGEN
by Zacks Equity Research
Emerson's (EMR) advanced technologies will enable KOHYGEN to develop a marketable hydrogen charging model to grow Korea's domestic hydrogen market.
What Makes Idex (IEX) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does Idex (IEX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Why Is Xylem (XYL) Up 7.8% Since Last Earnings Report?
by Zacks Equity Research
Xylem (XYL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
General Electric's (GE) Board Approves Healthcare Unit Spin-Off
by Zacks Equity Research
General Electric's (GE) board approves the separation of its healthcare unit into a separate public company. The spun-off entity is set to be renamed GE HealthCare Technologies Inc.
Stanley Black (SWK) Shares Plunge 57% YTD Amid Headwinds
by Zacks Equity Research
Stanley Black (SWK) is grappling with weakness in the Tools & Outdoor segment, supply-chain challenges, raw material cost inflation and foreign exchange woes.
Donaldson (DCI) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Donaldson's (DCI) Q1 earnings results reflect gains from its segments. Favorable pricing aided the margin growth.
Nordson (NDSN) Unveils SELECT Synchro to Boost Throughput
by Zacks Equity Research
The SELECT Synchro selective soldering helps electronics manufacturers by offering faster, more flexible, and more efficient operations compared with the traditional selective soldering solutions.
Here's Why You Should Hold Illinois Tool (ITW) Stock for Now
by Zacks Equity Research
Illinois Tool (ITW) is benefiting from a diversified business model, acquired assets and impressive shareholder-friendly policies.
Tetra Tech (TTEK) Wins Water and Sanitation Services Contract
by Zacks Equity Research
Tetra Tech (TTEK) to allocate funds to develop WASH services via USAID Water, Sanitation and Hygiene Finance 2 (WASH-FIN 2) activity.
End-Market Strength Aids Nordson (NDSN) Despite Cost Woes
by Zacks Equity Research
Strength in the end markets, acquired assets and shareholder-friendly policies benefit Nordson (NDSN). Rising costs and expenses, and supply-side challenges raise a concern.
General Electric (GE) to Offer CT Motion Injector in U.S.
by Zacks Equity Research
General Electric's (GE) Healthcare unit collaborates with Ulrich Medical to offer a multi-dose syringeless injector under the brand name CT Motion.
Here's Why It Is Apt to Retain Xylem (XYL) in Your Portfolio
by Zacks Equity Research
Xylem (XYL) stands to benefit from solid underlying market demand and pricing actions across its businesses. XYL's efforts to reward its shareholders with dividends augur well.